Snapshot from Sep 18, 2026 at 07:00 UTC. For live data and tracking: View Live
Business Executive Appointment

Immunic Appoints Chief Data Officer

Analysis based on 8 articles · First reported Sep 01, 2026 · Last updated Sep 01, 2026

Sentiment
10
Attention
1
Articles
8
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard

The appointment of a Chief Data and Digital Officer signals Immunic's preparation for commercial readiness, which may be viewed positively by investors as the company approaches key clinical milestones. The move is unlikely to have a significant immediate impact on the stock price, but it underscores the company's commitment to building infrastructure for potential NDA submission and commercialization.

Biotechnology Pharmaceuticals

Immunic, Inc. (Nasdaq: IMUX), a late-stage biotechnology company, announced the appointment of Chitrang Davé as Chief Data and Digital Officer (CDDO), effective September 1, 2026. Davé will report directly to CEO Ockelbo-Lundgren and join the executive leadership team. In this newly created role, he will lead the company's enterprise-wide data, analytics, AI, and digital strategy, supporting the preparation of the data package for a potential New Drug Application (NDA) for vidofludimus calcium (IMU-838) in multiple sclerosis. The appointment comes as Immunic prepares for top-line data from its Phase 3 ENSURE trials by year-end and plans for a confirmatory Phase 3 program in progressive MS. Davé brings over 25 years of experience, having previously served at Avidity Biosciences, Edwards Lifesciences, and Medtronic. As part of the appointment, Immunic granted Davé an option to purchase 120,000 shares of common stock under its 2026 Inducement Equity Compensation Plan, vesting over four years.

80 Immunic appointed Chitrang Davé
60 Immunic granted stock options Chitrang Davé
stock
Immunic is the central entity, appointing a new executive to strengthen its data and digital capabilities ahead of potential regulatory filing and commercialization. This move is part of its preparation for Phase 3 data readouts and NDA submission.
Importance 100.0 Sentiment 10.0
per
Chitrang Davé is the newly appointed Chief Data and Digital Officer, tasked with building Immunic's data ecosystem. His appointment and equity grant reflect the company's investment in leadership to support its transition to commercial readiness.
Importance 90.0 Sentiment 10.0
per
Ockelbo-Lundgren, as CEO, announced the appointment and will oversee Davé's integration into the executive team. His leadership is central to the company's strategic direction.
Importance 60.0 Sentiment 10.0
stock
Avidity Biosciences is mentioned as Davé's previous employer, providing context for his experience. No direct impact on Avidity from this event.
Importance 20.0 Sentiment 0.0
stock
Edwards Lifesciences is mentioned as a previous employer of Davé, highlighting his background. No direct impact on Edwards from this event.
Importance 20.0 Sentiment 0.0
stock
Medtronic is mentioned as a previous employer of Davé, where he spent 16 years. No direct impact on Medtronic from this event.
Importance 20.0 Sentiment 0.0
exch
Nasdaq is referenced as the exchange where Immunic is listed and as the source of the listing rule under which the equity grant was made. No direct impact on Nasdaq.
Importance 10.0 Sentiment 0.0
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.